本页面由Tiger Trade Technology Pte. Ltd.提供服务

Neumora Therapeutics, Inc.

0.4373
-0.0384-8.07%
盘后:0.44160.0043+0.98%19:52 EDT
成交量:121.09万
成交额:54.58万
市值:8,221.24万
市盈率:-0.36
高:0.4815
开:0.4815
低:0.4355
收:0.4757
52周最高:3.65
52周最低:0.4355
股本:1.88亿
流通股本:1.16亿
量比:0.63
换手率:1.04%
股息:- -
股息率:- -
每股收益(TTM):-1.2237
每股收益(LYR):-1.4501
净资产收益率:-187.11%
总资产收益率:-73.85%
市净率:1.85
市盈率(LYR):-0.30

数据加载中...

2026/08/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/19

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/19

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/14

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/08/14

重要事件披露

Form 8-K - Current report
2026/07/27

重要事件披露

Form 8-K - Current report
2026/06/15

重要事件披露

Form 8-K - Current report
2026/05/29

重要事件披露

Form 8-K - Current report
2026/05/15

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/07

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/05/07

重要事件披露

Form 8-K - Current report
2026/05/04

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/03/30

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/03/30

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/03/30

重要事件披露

Form 8-K - Current report
2026/02/18

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/18

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities